rs116446171
|
|
|
0.710 |
GeneticVariation |
BEFREE |
Three of the five genome-wide significant SNPs from the DLBCL GWAS were significantly associated with DLBCL in our study population, including the top finding from the GWAS, EXOC2 rs116446171, which achieved genome-wide significance in our data (per allele OR = 2.04, 95% CI = 1.63-2.56; ptrend = 3.9 × 10(-10)).
|
25611436 |
2015 |
rs116446171
|
|
G |
0.710 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs1323292
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs140522
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs1444766
|
|
G |
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs16978630
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs2425752
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs3890745
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs806321
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
|
31407831 |
2019 |
rs7712513
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
|
26460308 |
2015 |
rs7765004
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.
|
26460308 |
2015 |
rs13255292
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs2523607
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs2681416
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs4733601
|
|
A |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs79464052
|
|
C |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs79480871
|
|
T |
0.700 |
GeneticVariation |
GWASCAT |
Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma.
|
25261932 |
2014 |
rs751837
|
|
|
0.700 |
GeneticVariation |
GWASCAT |
Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility.
|
21471979 |
2011 |
rs111724149
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs35090414
|
|
|
0.700 |
GeneticVariation |
UNIPROT |
|
|
|
rs387907272
|
|
|
0.100 |
GeneticVariation |
BEFREE |
MYD88 p.L265P and CD79B p.Y196C/H mutations were analyzed in diffuse large B-cell lymphoma (DLBCL) patients whose tumor samples were available (N = 29).
|
31436356 |
2019 |
rs387907272
|
|
|
0.100 |
GeneticVariation |
BEFREE |
High frequencies of the hotspot <i>MYD88</i>(L265P) mutation are observed in extranodal diffuse large B-cell lymphoma and Waldenström macroglobulinemia, thereby demonstrating this mutation's potential as a disease marker.
|
31699794 |
2019 |
rs387907272
|
|
|
0.100 |
GeneticVariation |
BEFREE |
MYD88 L265P is the most common mutation in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) and one of the most frequent in poor-prognosis subtypes of diffuse large B-cell lymphoma (DLBCL).
|
31698464 |
2019 |
rs387907272
|
|
|
0.100 |
GeneticVariation |
BEFREE |
<i>Results</i>: MYD88 L265P mutations were detected in 22 of 29 samples from 14 patients with diffuse large B-cell lymphomas and one patient with lymphoplasmacytoid lymphoma.
|
31603365 |
2019 |
rs387907272
|
|
|
0.100 |
GeneticVariation |
BEFREE |
ST2825 has the potential for clinical use in patients with L265P DLBCL, and other B‑cell neoplasms driven by activated MYD88 signaling.
|
31432184 |
2019 |